Nimesulide prevents lipopolysaccharide-induced elevation in plasma tumor necrosis factor-α in rats

被引:17
作者
Azab, A [1 ]
Fraifeld, V [1 ]
Kaplanski, J [1 ]
机构
[1] Ben Gurion Univ Negev, Dept Clin Pharmacol, IL-84105 Beer Sheva, Israel
关键词
nimesulide; TNF-alpha; lipopolysaccharide; rat;
D O I
10.1016/S0024-3205(99)80011-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study was undertaken to test the hypothesis of possible inhibitory effect of nimesulide (4-nitro-2-phenoxymethane-sulfoxide) on plasma TNF-alpha level. Male Sprague-Dawley rats were injected intraperitoneally (ip) with E. coli Lipopolysaccharide (LBS; 1 mg/kg), which resulted in a dramatic increase in plasma TNF-alpha level peaked 60 min post injection (3890 +/- 280 pg/ml, compared to undetectable values in the control group). Nimesulide (30 mg/kg) injected ip 60 min prior to LPS, prevented LPS-induced elevation in plasma TNF-alpha. Nimesulide alone did not alter circulating levels of TNF-alpha. It appears that the anti-inflammatory properties of nimesulide may in part be attributed to its inhibitory effect on TNF-alpha production. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:PL323 / PL327
页数:5
相关论文
共 18 条
[1]   EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].
ABRAHAM, E ;
WUNDERINK, R ;
SILVERMAN, H ;
PERL, TM ;
NASRAWAY, S ;
LEVY, H ;
BONE, R ;
WENZEL, RP ;
BALK, R ;
ALLRED, R ;
PENNINGTON, JE ;
WHERRY, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941
[2]  
ABRAMOVICH L, 1997, THERMAL PHYSL, P313
[3]   The tumor necrosis factor ligand and receptor families [J].
Bazzoni, F ;
Beutler, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1717-1725
[4]   The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis [J].
Camussi, G ;
Lupia, E .
DRUGS, 1998, 55 (05) :613-620
[5]  
Caughey GE, 1997, J IMMUNOL, V158, P351
[6]   NIMESULIDE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY [J].
DAVIS, R ;
BROGDEN, RN .
DRUGS, 1994, 48 (03) :431-454
[7]  
Ferreira S H, 1993, Drugs, V46 Suppl 1, P1
[8]  
Hulkower KI, 1997, J PHARMACOL EXP THER, V280, P1065
[9]   Soluble tumor necrosis factor α receptor prevents decrease of body temperature in mice treated with indomethacin and lipopolysaccharide [J].
Kozak, W ;
Soszynski, D ;
Rudolph, K ;
Leon, LR ;
Conn, CA ;
Kluger, MJ .
THERMOREGULATION: TENTH INTERNATIONAL SYMPOSIUM ON THE PHARMACOLOGY OF THERMOREGULATION, 1997, 813 :264-271
[10]  
LONG NC, 1990, AM J PHYSIOL, V258, P332